SCHEMBL22260596

SCHEMBL22260596

CC(C)(C)c1ccc2c(c1)c1ccccc1n2-c1ccc2oc3ccc(CC(C)(C)c4cccc5c4oc4ccccc45)cc3c2c1

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
PGR P06401 1/20 0.31
RORA P35398 1/20 0.31
RORC P51449 1/20 0.31
RORB Q92753 1/20 0.31
GGPS1 O95749 1/20 0.31
KDM4E B2RXH2 1/20 0.30
NPC1 O15118 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29317003 0.88 CYP2C19 (0.40) CYP2C19CYP1A2CYP2D6MEN1KMT2A
SCHEMBL19866512 0.84 MEN1 (0.37) CYP2C19CYP1A2CYP2D6MEN1KMT2A
SCHEMBL25003892 0.84 PGR (0.35) CYP2C19CYP1A2CYP2D6MEN1KMT2A
SCHEMBL15801370 0.83 MAPT (0.39) CYP2C19CYP1A2CYP2D6MEN1KMT2A
SCHEMBL19068354 0.82 KDM4E (0.35) CYP2C19CYP1A2CYP2D6PGRRORA
SCHEMBL15959668 0.80 KDM4E (0.40) MEN1KMT2APGRRORARORC
SCHEMBL24810389 0.79 PGR (0.31) PGRRORARORCRORBGGPS1
SCHEMBL25028749 0.79 MEN1 (0.32) CYP2C19MEN1KMT2A
SCHEMBL20115865 0.78 ALDH1A1 (0.38) MEN1KMT2APGRRORARORC
SCHEMBL20935757 0.76 KDM4E (0.40) CYP2C19CYP1A2PGRRORARORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200235315-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200235315-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME TRPA1, PIEZO1, SLCO4C1 CYP2C19 1197/4885CYP1A2 1799/4885CYP2D6 1637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.